Intellectual Property Contracts & Agreements in the Biotechnology Industry

2,773 Contracts & Agreements

Browse by Subcategory

License Agreements (2,753 contracts from 509 companies)
Trademark Agreements (20 | 9)

Browse by Company

2seventy bio, Inc. (4 contracts)
4D Molecular Therapeutics Inc (4)
89bio, Inc. (1)
ABEONA THERAPEUTICS INC. (6)
ACADIA PHARMACEUTICALS INC (7)
ACCELERON PHARMA INC (2)
Accustem Sciences Inc. (1)
Achaogen, Inc. (6)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (25)
Actinium Pharmaceuticals, Inc. (4)
Acumen Pharmaceuticals, Inc. (1)
Adagio Therapeutics, Inc. (2)
Adamas Pharmaceuticals Inc (2)
Adhera Therapeutics, Inc. (15)
ADiTx Therapeutics, Inc. (1)
ADMA BIOLOGICS, INC. (2)
ADURO BIOTECH, INC. (16)
Advaxis, Inc. (5)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (6)
AGENUS INC (20)
AGIOS PHARMACEUTICALS INC (2)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (2)
Akebia Therapeutics, Inc. (6)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (6)
Aldeyra Therapeutics, Inc. (3)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (4)
Alkermes plc. (10)
Allakos Inc. (6)
Allarity Therapeutics, Inc. (16)
Allena Pharmaceuticals, Inc. (2)
Alliqua BioMedical, Inc. (5)
Allogene Therapeutics, Inc. (1)
Allovir, Inc. (3)
ALNYLAM PHARMACEUTICALS, INC. (5)
Alpha Healthcare Acquisition Corp. (10)
ALPINE IMMUNE SCIENCES, INC. (5)
Altimmune, Inc. (9)
Alzamend Neuro, Inc. (5)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (4)
Amgen Inc. (2)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (2)
Amplitude Healthcare Acquisition Corp (1)
ANAPTYSBIO INC (2)
Anika Therapeutics (3)
Anixa Biosciences Inc (6)
Annovis Bio, Inc. (3)
Apellis Pharmaceuticals, Inc. (2)
APPLIED GENETIC TECHNOLOGIES CORP (12)
Applied Therapeutics Inc. (2)
Aptevo Therapeutics Inc. (5)
Aptose Biosciences Inc. (1)
AQUINOX PHARMACEUTICALS, INC (3)
Aravive, Inc. (6)
Arbutus Biopharma Corp (7)
ARCA biopharma, Inc. (10)
Arcellx, Inc. (1)
Arcus Biosciences, Inc. (7)
Arcutis Biotherapeutics, Inc. (3)
ARDELYX, INC. (9)
ARENA PHARMACEUTICALS INC (3)
Aridis Pharmaceuticals, Inc. (5)
ARROWHEAD PHARMACEUTICALS, INC. (8)
Arsanis, Inc. (11)
Artiva Biotherapeutics, Inc. (7)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (4)
Atara Biotherapeutics, Inc. (14)
Athenex, Inc. (37)
ATHERSYS, INC (5)
ATOSSA GENETICS INC (7)
Atreca, Inc. (2)
Aura Biosciences, Inc. (3)
AVEO PHARMACEUTICALS INC (10)
Avid Bioservices, Inc. (6)
AVROBIO, Inc. (9)
Axovant Sciences Ltd. (4)
Ayala Pharmaceuticals, Inc. (3)
AZIYO BIOLOGICS, INC. (2)
AzurRx BioPharma, Inc. (2)
Beam Therapeutics Inc. (8)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (9)
BICYCLE THERAPEUTICS Ltd (1)
BIO-PATH HOLDINGS INC (2)
bioAffinity Technologies, Inc. (2)
BioAtla, Inc. (4)
BioCardia, Inc. (1)
BIOCRYST PHARMACEUTICALS INC (4)
Biohaven Pharmaceutical Holding Co Ltd. (8)
BioLife4D Corp (4)
BIOMARIN PHARMACEUTICAL INC (8)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (7)
Biostage, Inc. (3)
BIOTIME INC (19)
BioXcel Therapeutics, Inc. (1)
BIOXYTRAN, INC (4)
Blue Water Vaccines Inc. (8)
bluebird bio, Inc. (20)
Blueprint Medicines Corp (1)
Bone Biologics Corp (7)
BRAINSTORM CELL THERAPEUTICS INC. (1)
BriaCell Therapeutics Corp. (1)
BridgeBio Pharma, Inc. (6)
BullFrog AI Holdings, Inc. (10)
BURZYNSKI RESEARCH INSTITUTE INC (1)
C4 Therapeutics, Inc. (3)
Cabaletta Bio, Inc. (4)
CALADRIUS BIOSCIENCES, INC. (5)
Calithera Biosciences, Inc. (1)
Calyxt, Inc. (3)
Candel Therapeutics, Inc. (6)
CAPRICOR THERAPEUTICS, INC. (13)
Capstone Therapeutics Corp. (6)
CareDx, Inc. (2)
Caribou Biosciences, Inc. (8)
CASI Pharmaceuticals, Inc. (7)
CASTLE BIOSCIENCES INC (1)
CATALYST BIOSCIENCES, INC. (30)
CATALYST PHARMACEUTICALS, INC. (10)
Celcuity Inc. (2)
Cell Source, Inc. (4)
Celldex Therapeutics, Inc. (7)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (4)
Centessa Pharmaceuticals Ltd (4)
Century Therapeutics, Inc. (8)
CEREBAIN BIOTECH CORP. (1)
Chanticleer Holdings, Inc. (3)
Chardan Healthcare Acquisition 2 Corp. (1)
Chardan Healthcare Acquisition Corp. (4)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (5)
CHIMERIX INC (4)
Cidara Therapeutics, Inc. (1)
CLEVELAND BIOLABS INC (4)
CM Life Sciences III Inc. (2)
CohBar, Inc. (2)
Coherus BioSciences, Inc. (10)
Conatus Pharmaceuticals Inc. (6)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (1)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (3)
Cortexyme, Inc. (4)
Corvus Pharmaceuticals, Inc. (3)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
Crinetics Pharmaceuticals, Inc. (1)
CTI BIOPHARMA CORP (4)
Cue Biopharma, Inc. (14)
Cullinan Oncology, LLC (3)
Curative Biotechnology Inc (17)
CURIS INC (2)
Cyclacel Pharmaceuticals, Inc. (7)
Cyclerion Therapeutics, Inc. (1)
CytoDyn Inc. (2)
Cytokinetics, Incorporated (1)
CytomX Therapeutics, Inc. (5)
CYTORI THERAPEUTICS, INC. (6)
CYTRX CORP (2)
Day One Biopharmaceuticals Holding Co LLC (3)
Decibel Therapeutics, Inc. (8)
Deciphera Pharmaceuticals, Inc. (1)
Denali Therapeutics Inc. (1)
Dermavant Sciences Ltd (10)
Dermira, Inc. (3)
Design Therapeutics, Inc. (1)
Dicerna Pharmaceuticals Inc (4)
Diffusion Pharmaceuticals Inc. (4)
Digital Development Partners, Inc. (1)
DYADIC INTERNATIONAL INC (3)
Dynamics Special Purpose Corp. (4)
DYNAVAX TECHNOLOGIES CORP (1)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (11)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (8)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (13)
Elevation Oncology, Inc. (2)
Emerald Bioscience, Inc. (9)
Emergent BioSolutions Inc. (1)
Enanta Pharmaceuticals, Inc. (1)
Enochian Biosciences Inc (2)
Entrada Therapeutics, Inc. (2)
ENZOLYTICS INC (1)
Epizyme, Inc. (2)
Erasca, Inc. (4)
Esperion Therapeutics, Inc. (1)
Evelo Biosciences, Inc. (6)
EXACT SCIENCES CORP (15)
Exelixis (5)
EXICURE, INC. (13)
FATE THERAPEUTICS INC (17)
FENNEC PHARMACEUTICALS INC. (1)
Fibrocell Science, Inc. (3)
FIBROGEN INC (9)
Finch Therapeutics Group, Inc. (4)
FIVE PRIME THERAPEUTICS INC (12)
Flex Pharma, Inc. (7)
Flexion Therapeutics Inc (2)
FLUOROPHARMA MEDICAL, INC. (2)
Forma Therapeutics Holdings, Inc., (2)
Fortress Biotech, Inc. (1)
Frequency Therapeutics, Inc. (3)
FS Development Corp. (5)
Fusion Pharmaceuticals Inc. (2)
G1 Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (1)
Gemphire Therapeutics Inc. (3)
Gene Biotherapeutics, Inc. (11)
GENELUX CORP (4)
Generation Bio Co. (4)
GENOCEA BIOSCIENCES, INC. (2)
Genprex, Inc. (10)
GeoVax Labs, Inc. (5)
GERON CORP (6)
Gilead Sciences (11)
Global Blood Therapeutics, Inc. (2)
GLYCOMIMETICS INC (2)
GOLDENWELL BIOTECH, INC. (2)
Gossamer Bio, Inc. (3)
Grail, Inc. (5)
Graphite Bio, Inc. (7)
Greater Cannabis Company, Inc. (1)
Greenwich LifeSciences, Inc. (3)
Gritstone Oncology, Inc. (3)
GT Biopharma, Inc. (17)
GTX INC (21)
HARBOR DIVERSIFIED, INC. (4)
Harpoon Therapeutics, Inc. (3)
HCW Biologics Inc. (1)
Health Sciences Acquisitions Corp (2)
HEAT BIOLOGICS, INC. (32)
HedgePath Pharmaceuticals, Inc. (5)
HilleVax, Inc. (1)
HISTOGENICS CORP (16)
Homology Medicines, Inc. (5)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (1)
iBio, Inc. (5)
Icosavax, Inc. (8)
IDEAYA Biosciences, Inc. (4)
IDERA PHARMACEUTICALS, INC. (5)
Immix Biopharma, Inc. (2)
IMMUCELL CORP (2)
IMMUNE PHARMACEUTICALS INC (7)
Immune Therapeutics, Inc. (8)
ImmunoCellular Therapeutics, Ltd. (11)
IMMUNOGEN INC (14)
Immunome Inc. (3)
IMMUNOMEDICS INC (3)
IN8BIO, INC. (8)
Incyte (4)
INFINITY PHARMACEUTICALS, INC. (5)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (7)
Inmune Bio, Inc. (9)
Innovation Pharmaceuticals Inc. (1)
INOVIO PHARMACEUTICALS, INC. (3)
Inozyme Pharma, Inc. (1)
INSMED Inc (6)
Intellia Therapeutics, Inc. (12)
INTERCEPT PHARMACEUTICALS, INC. (10)
International Stem Cell CORP (9)
INTREXON CORP (1)
Intrinsic Medicine, Inc. (7)
IONIS PHARMACEUTICALS INC (21)
IOVANCE BIOTHERAPEUTICS, INC. (3)
IRONWOOD PHARMACEUTICALS INC (9)
Isoray, Inc. (11)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (2)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (1)
Karuna Therapeutics, Inc. (3)
Karyopharm Therapeutics Inc. (4)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (2)
Kiniksa Pharmaceuticals, Ltd. (4)
Kiromic Biopharma, Inc. (4)
Kura Oncology, Inc. (9)
LA JOLLA PHARMACEUTICAL CO (2)
Lantern Pharma Inc. (6)
LEAP THERAPEUTICS, INC. (3)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (19)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (23)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
Locust Walk Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (5)
LONGEVERON LLC (5)
Lyell Immunopharma, Inc. (1)
MACROGENICS INC (4)
MADRIGAL PHARMACEUTICALS, INC. (2)
Magenta Therapeutics, Inc. (6)
MAIA Biotechnology, Inc. (6)
MANHATTAN SCIENTIFICS INC (1)
Marker Therapeutics, Inc. (2)
MATEON THERAPEUTICS INC (8)
Matinas BioPharma Holdings, Inc. (1)
MEDICINOVA INC (8)
MEI Pharma, Inc. (6)
MeiraGTx Holdings plc (9)
MERRIMACK PHARMACEUTICALS INC (1)
Mersana Therapeutics, Inc. (7)
Merus N.V. (1)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (11)
MiMedx Group, Inc. (13)
Minerva Neurosciences, Inc. (8)
MiNK Therapeutics, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (13)
Mirum Pharmaceuticals, Inc. (7)
Molecular Templates, Inc. (6)
Moleculin Biotech, Inc. (13)
Momenta Pharmaceuticals, Inc. (2)
Monopar Therapeutics (10)
Monte Rosa Therapeutics, Inc. (1)
Morphic Holding, Inc. (2)
MUSTANG BIO, INC. (6)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (2)
NANOVIRICIDES, INC. (3)
NantKwest, Inc. (12)
Natera, Inc. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (5)
NEUROBIOLOGICAL TECHNOLOGIES INC (5)
NEUROCRINE BIOSCIENCES INC (2)
NEUROTROPE BIOSCIENCE, INC. (3)
Neurotrope, Inc. (1)
NEWLINK GENETICS CORP (45)
NexImmune, Inc. (1)
NextCure, Inc. (2)
Nkarta, Inc. (1)
NOVAVAX INC (8)
Novus Therapeutics, Inc. (3)
NTN BUZZTIME INC (5)
Nuo Therapeutics, Inc. (7)
Nuvectis Pharma, Inc. (4)
Ohr Pharmaceutical Inc (2)
Omega Therapeutics, Inc. (4)
OncoCyte Corp (4)
Oncorus, Inc. (7)
ONCOSEC MEDICAL Inc (1)
Ophthotech Corp. (7)
Opko Health, Inc. (12)
ORAGENICS INC (10)
Orchard Therapeutics plc (1)
Organogenesis Holdings Inc. (1)
ORGANOVO HOLDINGS, INC. (5)
Oric Pharmaceuticals, Inc. (1)
Outlook Therapeutics, Inc. (3)
Ovid Therapeutics Inc. (4)
Oyster Point Pharma, Inc. (1)
PALATIN TECHNOLOGIES INC (2)
PepGen Inc. (2)
Pfenex Inc. (13)
PharmaCyte Biotech, Inc. (3)
PhaseBio Pharmaceuticals Inc (7)
PIERIS PHARMACEUTICALS, INC. (7)
PLURISTEM THERAPEUTICS INC (2)
POLARITYTE, INC. (3)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (10)
Praxis Precision Medicines, Inc. (2)
PRECISION BIOSCIENCES INC (8)
Prelude Therapeutics Inc (2)
PREMIER BIOMEDICAL INC (6)
Prevail Therapeutics Inc. (2)
Principia Biopharma Inc. (5)
Progenics Pharmaceuticals, Inc. (9)
Prometheus Biosciences, Inc. (5)
Protagenic Therapeutics, Inc. (3)
Protagonist Therapeutics, Inc (1)
Protalix BioTherapeutics, Inc. (7)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (9)
Prothena Corp plc (12)
PTC THERAPEUTICS, INC. (4)
PUMA BIOTECHNOLOGY, INC. (14)
Pyxis Oncology, Inc. (7)
Q BioMed Inc. (3)
Qrons Inc. (5)
Radius Health, Inc. (5)
Rallybio Corp (4)
RECURSION PHARMACEUTICALS, INC. (3)
Regeneron Pharmaceuticals (11)
REGENERX BIOPHARMACEUTICALS INC (3)
REGENXBIO Inc. (33)
Regulus Therapeutics Inc. (1)
Reneo Pharmaceuticals, Inc. (1)
Repare Therapeutics Inc. (1)
Retrophin, Inc. (10)
REXAHN PHARMACEUTICALS, INC. (5)
Rezolute, Inc. (6)
RHYTHM PHARMACEUTICALS, INC. (5)
RIGEL PHARMACEUTICALS INC (3)
RITTER PHARMACEUTICALS INC (12)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (6)
Sana Biotechnology, Inc. (34)
SANGAMO THERAPEUTICS, INC (14)
Sarepta Therapeutics, Inc. (7)
Savara Inc (5)
SEATTLE GENETICS INC (9)
SELECTA BIOSCIENCES INC (5)
SELLAS Life Sciences Group, Inc. (37)
Sensei Biotherapeutics, Inc. (1)
Seres Therapeutics, Inc. (2)
Sesen Bio, Inc. (6)
Shattuck Labs, Inc. (1)
Sierra Oncology, Inc. (5)
Sigilon Therapeutics, Inc. (7)
Silverback Therapeutics, Inc. (4)
Social Capital Suvretta Holdings Corp. III (1)
Solid Biosciences Inc. (12)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (4)
Sorrento Therapeutics, Inc. (13)
Spectrum Pharmaceuticals, Inc. (11)
Spero Therapeutics, Inc. (8)
SPHERIX INC (5)
Spring Bank Pharmaceuticals, Inc. (1)
SpringWorks Therapeutics, Inc. (2)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (1)
Stellar Biotechnologies, Inc. (8)
Stoke Therapeutics, Inc. (4)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (3)
Sunshine Biopharma, Inc (2)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (3)
Syndax Pharmaceuticals Inc (15)
SYNLOGIC, INC. (16)
Synthetic Biologics, Inc. (10)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (1)
Talaris Therapeutics, Inc. (3)
Taysha Gene Therapies, Inc. (3)
TENAX THERAPEUTICS, INC. (8)
Tenaya Therapeutics, Inc. (1)
TG THERAPEUTICS, INC. (3)
Therapeutics Acquisition Corp. (2)
Tocagen Inc (4)
Tonix Pharmaceuticals Holding Corp. (6)
Tracon Pharmaceuticals, Inc. (7)
Transcode Therapeutics, Inc. (2)
Translate Bio, Inc. (2)
TREVENA INC (1)
Trovagene, Inc. (2)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (3)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (18)
Unicycive Therapeutics, Inc. (3)
uniQure N.V. (5)
United Therapeutics Corp (4)
Unity Biotechnology, Inc. (29)
Unum Therapeutics Inc. (1)
UroGen Pharma Ltd. (1)
VACCINEX, INC. (2)
Vaccitech plc (4)
Vanda Pharmaceuticals Inc. (11)
Vaxart, Inc. (1)
Vaxcyte, Inc. (1)
Vaxxinity, Inc. (1)
VBI Vaccines Inc (1)
Vera Therapeutics, Inc. (4)
Verastem, Inc. (3)
Vericel Corp (6)
Vertex Pharmaceuticals Inc (2)
Verve Therapeutics, Inc. (2)
VICAL INC (20)
Vicapsys Life Sciences, Inc. (2)
Viela Bio, Inc. (2)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (3)
Vir Biotechnology, Inc. (14)
Virios Therapeutics, LLC (1)
VistaGen Therapeutics, Inc. (8)
VITAL THERAPIES INC (1)
Vor Biopharma Inc. (4)
Voyager Therapeutics, Inc. (5)
vTv Therapeutics Inc. (10)
Werewolf Therapeutics, Inc. (1)
WINDTREE THERAPEUTICS INC (5)
XBiotech Inc. (1)
Xencor Inc (8)
Xenetic Biosciences, Inc. (7)
Xenon Pharmaceuticals Inc. (5)
Xilio Therapeutics, Inc. (2)
XOMA Corp (18)
Y-mAbs Therapeutics, Inc. (4)
YIELD10 BIOSCIENCE, INC. (1)
Yulong Eco-Materials Ltd (2)
ZAFGEN, INC. (8)
Zai Lab Ltd (5)
Zentalis Pharmaceuticals, LLC (4)
ZIOPHARM ONCOLOGY INC (9)

Recent Contracts

Strategic Relationship License Agreement, dated December 1, 2022, by and between Pathology Watch, Inc. and Precision Pathology Services (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
Development and Exclusive License Agreement,effectiveSeptember 18, 2023 (DYADIC INTERNATIONAL INC, Filed With SEC on September 19, 2023)
License Agreement, dated May 24, 2023, by and between the Company and MEDICE Arzneimittel Ptter GmbH & Co. KG (Akebia Therapeutics, Inc., Filed With SEC on August 28, 2023)
License Agreement, effective as of August 15, 2023 by and between Precision BioSciences, Inc. and Imugene (USA) Inc (PRECISION BIOSCIENCES INC, Filed With SEC on August 21, 2023)
Amended and Restated Exclusive License Agreement, dated June 8, 2023, between the Registrant and the University of Washington (Icosavax, Inc., Filed With SEC on August 14, 2023)
Amendment No. 3 to Exclusive Patent License Agreement, dated May 24, 2023, between the Registrant and National Institute of Allergy and Infectious Diseases (Icosavax, Inc., Filed With SEC on August 14, 2023)
Amendment No. 4 to License Agreement by and between Pyxis Oncology, Inc. and Biosion USA, Inc, dated May 17, 2023 (Pyxis Oncology, Inc., Filed With SEC on August 11, 2023)
Amendment No. 2 to the Exclusive License Agreement, dated July 27, 2023, between Stanford University and Jasper Therapeutics, Inc (Amplitude Healthcare Acquisition Corp, Filed With SEC on August 11, 2023)
Second Amendment to Option and License Agreement (CD27), dated as of December 21, 2022, by and between Gigagen, Inc. and the Company (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on August 11, 2023)
First Amendment to the License and Supply Agreement, dated as of May 2, 2023, between the Registrant and Oxford Biomedica (UK) Limited (Cabaletta Bio, Inc., Filed With SEC on August 10, 2023)
Amendment to Exclusive License Agreement by and between Candel Therapeutics, Inc. and Periphagen, Inc., dated June 7, 2023 (Candel Therapeutics, Inc., Filed With SEC on August 10, 2023)
Third Amended and Restated License Agreement, dated June 5, 2023, by and between Zeno Management, Inc. and Recurium IP Holdings, LLC (Zentalis Pharmaceuticals, LLC, Filed With SEC on August 9, 2023)
Master License Agreement, by and between Morphimmune, Inc. and Purdue Research Foundation, dated as of January 19, 2021, as modified pursuant to that certain email by Max Rosett... (Immunome Inc., Filed With SEC on August 8, 2023)
Amendment No. 1 to the License of Technology Agreement, dated February 12, 2021, by and among Oxford University Innovation Limited, Medical Research Counsel as part of the United... (PepGen Inc., Filed With SEC on August 8, 2023)
Amended and Restated Exclusive License Agreement by and among FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd., and Eluminex Biosciences Suzhou) Limited,... (FIBROGEN INC, Filed With SEC on August 7, 2023)
Exclusive License Agreement by and between the Registrant and Washington University, dated November 11, 2013 (Sage Therapeutics, Inc., Filed With SEC on August 7, 2023)
Non-Exclusive License Agreement by and between the Registrant and the Regents of University of California, dated October 23, 2013, as amended May 14, 2014 (Sage Therapeutics, Inc., Filed With SEC on August 7, 2023)
Commercial License Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated August 21, 2013, as amended April 30, 2014 (Sage Therapeutics, Inc., Filed With SEC on August 7, 2023)
Amendment No. 5 to License Agreement dated April 28, 2023 by and between Shiratori Pharmaceutical Co. Ltd. and PTC Therapeutics MP, Inc (PTC THERAPEUTICS, INC., Filed With SEC on August 3, 2023)
Amendment No. 3 to License Agreement dated June 22, 2023 by and between Purdue Research Foundation and Novosteo Inc (Cortexyme, Inc., Filed With SEC on August 3, 2023)
Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms with the University of South Florida Research Foundation, Inc., dated April 16, 2023 (Alzamend Neuro, Inc., Filed With SEC on July 27, 2023)
Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC19050 with the University of South Florida Research Foundation, Inc., dated April 16,... (Alzamend Neuro, Inc., Filed With SEC on July 27, 2023)
Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC19051 with the University of South Florida Research Foundation, Inc., dated April 16,... (Alzamend Neuro, Inc., Filed With SEC on July 27, 2023)
Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC18110 with the University of South Florida Research Foundation, Inc., dated June 8, 2023 (Alzamend Neuro, Inc., Filed With SEC on July 27, 2023)
Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC18111 with the University of South Florida Research Foundation, Inc., dated June 8, 2023 (Alzamend Neuro, Inc., Filed With SEC on July 27, 2023)
License Agreement Term Sheet dated July 17, 2023 (Qrons Inc., Filed With SEC on July 24, 2023)
License Agreement by and between Tourmaline Bio, LLC and Lonza Sales AG, dated May 16, 2022 (Talaris Therapeutics, Inc., Filed With SEC on July 20, 2023)
License Agreement by and between Tourmaline Bio, LLC and Pfizer Inc., dated May 3, 2022 (Talaris Therapeutics, Inc., Filed With SEC on July 20, 2023)
Exclusive License Agreement, dated July 14, 2023 (Genprex, Inc., Filed With SEC on July 18, 2023)
First Amendment to Exclusive License Agreement, dated as of July 12, 2023, by and between Eterna Therapeutics Inc. and Factor Bioscience Limited (NTN BUZZTIME INC, Filed With SEC on July 13, 2023)
Third Amendment to the Exclusive License Agreement with Eisai, Inc (Allarity Therapeutics, Inc., Filed With SEC on June 7, 2023)
Amendment No. 1 to License Agreement between Bullfrog AI, Inc. and the Johns Hopkins University Applied Physics Laboratory LLC dated June 1, 2023 (BullFrog AI Holdings, Inc., Filed With SEC on June 5, 2023)
Ninth Amendment tot eh Exclusive Patent License Agreement (Vicapsys Life Sciences, Inc., Filed With SEC on June 2, 2023)
Second Amendment to Option and License Agreement (VISTA), dated as of May 25, 2023, by and between Gigagen, Inc. and Kineta, Inc (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on May 30, 2023)
Third Amendment to Option and License Agreement (CD27), dated as of May 25, 2023, by and between Gigagen, Inc. and Kineta, Inc (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on May 30, 2023)
License Agreement, dated May 22, 2023, by and between the Company and Dr. Stanislaw R. Burzynski (BURZYNSKI RESEARCH INSTITUTE INC, Filed With SEC on May 22, 2023)
Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated June 5, 2018 (Isoray, Inc., Filed With SEC on May 15, 2023)
Second Amendment, dated as of March 13, 2023, to the License Agreement, by and between the University of Florida Research Foundation, Inc. and the Registrant (Decibel Therapeutics, Inc., Filed With SEC on May 15, 2023)
Know-How License Agreement between Viewpoint Molecular Targeting, Inc. and Mayo Foundation For Medical Education and Research, dated February 22. 2022 (Isoray, Inc., Filed With SEC on May 15, 2023)
Amendment #1 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated July 31, 2018 (Isoray, Inc., Filed With SEC on May 15, 2023)